The objectives of the policy are to integrate all the elements of B-BBEE into the relevant authority’s activities in relation to its function of issuing licenses as envisaged in section 22C of the Medicines Act.
Stakeholders are encouraged to comment on the draft policy by 31 August 2023 on the SAHPRA website.
Submissions may be directed to SAHPRA through the ‘Contact Us’ page on their website. Please click here for the link: https://www.sahpra.org.za/general-enquiries-2/
